Hence, the addition of blocking antibodies against the PD-1/PD-L1 axis or against TIM-3 effectively restored IFN-γ and TNF-α production by T cells in response to tumour antigens (Fig. 3f, g). The gene discussed is HAVCR2; the disease is neoplasm.